BTG announced on 30 July that the National Institute for Health and Clinical Excellence (NICE) has issued guidance recommending the use of selective internal radiation therapy (SIRT), which includes TheraSphere, for patients with liver cancer across the NHS.
Sirtex Medical and US-based Surefire Medical has announced a sales and marketing partnership to distribute Surefire’s range of innovative infusion systems and specialty catheters for the interventional radiology and oncology markets.
Launched by the Assistance Publique Hôpitaux de Paris, France, in December 2011, SARAH (Sorafenib versus radioembolization in advanced hepatocellular carcinoma), a French national collaborative randomised controlled trial of radioembolization with yttrium-90 resin microspheres vs. sorafenib in advanced hepatocellular carcinoma has announced it is seeking to enrol 400 patients.
Cancer experts have reported future trends and progress in radiotherapy treatments for lung cancer using motion management and tumour-tracking technologies from Varian Medical Systems at the annual ESTRO Forum (19–23 April 2013, Geneva, Switzerland).
Better outcomes can be achieved for prostate cancer patients using brachytherapy, a highly targeted form of radiotherapy, compared to surgery according to study findings conducted by Panaxea, The University of Twente, The Netherlands.
Elekta recently received 510(k) clearance from the US Food and Drug Administration (FDA) which allows the company to begin shipping and installation of all components of the Versa HD system within the USA.
On 11–12 April, Nordion will host its 3rd European TheraSphere User Group Meeting in Vienna, Austria, and on 18 April, Nordion will offer a Satellite Symposium at the 3rd Interdisciplinary Treatment of Liver Tumors (ITLT) Meeting in Essen, Germany, according to a company release.
BSD Medical announced today that the company has signed an exclusive, long-term, multi-million dollar distribution agreement with Terumo Europe, a wholly owned subsidiary of Terumo Corporation, for the MicroThermX Microwave Ablation System.
Nordion a leading provider of products and services for the prevention, diagnosis and treatment of disease, will host an educational session called “TheraSphere test flight interactive: How to treat or should I treat?” at the Society for Interventional Radiology’s (SIR) Annual Scientific Meeting (13–18 April, New Orleans, USA).
Portable Medical, according to the company website, has received the CE mark for its oncology decision-making smartphone app—ONCOassist. The app was developed in conjunction with doctors and is classed as a medical device in accordance with EU regulations.
Prostate patients, according to data announced by the Diagnostic Center for Disease, Florida, USA, said that there could be a 95% cure rate when biopsy is used in conjunction with 3 telsa magnetic resonance imaging spectroscopy.
According to Surefire Medical and a study published in CardioVascular and Interventional Radiology, the Surefire infusion system can prevent embolics, such as those used for treating liver cancer, entering distal non-target vessels.
According to results of a study published in the Journal of Vascular and Interventional Radiology, a transcatheter arterial chemoembolization (TACE) procedure using an emulsion of lipidol, an anthracycline agent and gelatin sponge particles, in Asia, was favourable for patient outcomes compared with Western TACE.
In a study published in the Journal of Vascular and Interventional Radiology, Siddharth A Padia and colleagues compared 100–300µm and 300–500µm drug-eluting beads for the treatment of hepatocellular carcinoma patients.
The IN.PACT Admiral drug-eluting balloon (DEB) has been granted CE mark for arteriovenous (AV) access to help maintain haemodialysis access in patients with end-stage renal disease, according to a M...